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INTRODUCTION  
Secondary metabolites are very wide-ranging 
groups of compounds produced by organisms under 
certain conditions such as nutrient limitation, 
defence mechanisms, and regulator molecules 
(Samuelsson, 2004; Castillo, 2008). In fact, 
organisms producing secondary metabolites have 
attracted scientists from different disciplines such 
as chemistry, pharmacology, and biology. The 
studies conducted by chemists, pharmacologist, and 
biologist on secondary metabolites have led to the 
discovery of thousands of secondary metabolites 
with promising biological activities (Mayer et al., 
2011; Adam and Abdull Rasad, 2015; Majali et al., 
2015).  
 
Traditionally, terrestrial plants were the main 
sources of drugs. Presently, plants still provide 
many new potent drugs. Until 1950, the research on 
the chemistry of natural products was limited 
mainly to the investigation of terrestrial plants. 
After that, the search for bioactive compounds was 
extended to microorganisms. For more than 30 
years, marine natural products have attracted the 
attention of scientists to isolate novel biologically 
active metabolites (Fusetani, 2010; Qaralleh et al., 
2010; Shawa et al., 2015).  
 
Marine organisms are not widely used in traditional 
medicine, but currently they represent an enormous 
resource for the development of potential 
therapeutic agents (Pomponi, 1999).  Most of the 
marine organisms are soft-bodied and they are not 
able to use mechanical defence mechanisms like 
shelter or ability to escape, thus they need chemical 
defence mechanisms to survive (Debitus, 1998). 
Therefore, they have created an efficient defence 
mechanism that helps them to survive during 
evolution and to avoid extinction (Muller et al., 
1999). This mechanism encompasses the ability to 
synthesise or accumulate toxic metabolites and the 
secretion of highly toxic metabolites as they are 
rapidly diluted in the ocean water (Haefner, 2003). 
The metabolites secreted by marine organisms are 
characterised by the presence of halogen unlike the 
terrestrial secondary metabolites (Rinehart, 1992; 
Faulkner, 2002). For these reasons, and because of 
the high biological diversity in the sea (Mayer and 
Lehmann, 2000; Proksch et al., 2002), marine 
organisms have attracted researchers to find useful 
drugs for mankind (Satheeshkumar et al., 2010). 
 
Therefore, the aim of this paper is to review the 
antimicrobial alkaloids isolated from marine 
sponges, primarily focusing on their phytochemical 
characteristics. 
 
Sponges 
Sponges represent the major rich organisms with 
promising active pharmaceutical metabolites. The 
interest for drugs discovery in sponges has started 
since 1950s due to the discovery of the nucleosides 
spongothymidine and spongouridine from the 
marine sponge Cryptotethya crypta (Laport et al., 
2009). Both metabolites were later developed to 
ara-C, the first marine-derived anticancer agent, 
and the antiviral drug ara-A (Proksch et al., 2002). 
Later, several promising metabolites were 
discovered from marine sponges with different 
biological activities including antimicrobial and 
anticancer (Kobayashi, 2000). By far, more than 
36% of the metabolites discovered from marine 
organisms were isolated from sponges. 
Sponge crude extracts showed variable 
antimicrobial activities against terrestrial 
pathogenic bacteria, and against marine bacteria. 
Reports have shown that terrestrial microbes are 
more sensitive than marine microbes (Becerro et 
al., 1994; Newbold et al., 1999). Due to the 
presence of antimicrobial substances, sponges are 
rarely infected by exogenous microbes (Newbold et 
al., 1999). 
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Table 1: Antimicrobial alkaloids isolated from marine sponges 
Metabolites Inhibited Microorganisms References 
Arenosclerins A, B, C (1-3) and 
haliclonacyclamine E (4) 
S. aureus  Torres et al. (2002) 
Nagelamide A (5) Micrococcus luteus, Bacillus subtilis, and E. 
coli  
Endo et al. (2004) 
Cribrostatin 6 (6) S. pneumoniae  Pettit et al. (2004) 
Purpuramine L (7)  S. aureus, B. subtilis, and Chromobacterium 
violaceum  
Goud et al. (2003) 
Ptilocaulis guanidine (8) S. aureus  Yang et al. (2003a) 
Isoaaptamine (9) S. aureus  Jang et al. (2007a) 
Deoxytopsentin (10) S. aureus  Oh et al. (2005) 
Hamacanthin A (11) S. aureus  Oh et al. (2005) 
Batzellaside A (12) Staphylococcus epidermidis  Segraves and Crews, 
(2005) 
Dendridine A (13)  B. subtilis and Micrococcus luteus  Tsuda et al. (2005) 
Batzelladine L and M (14, 15)  S. aureus and methicillin resistant S. aureus  Hua et al. (2007) 
Massadine (16) C. albicans  Nishimura et al. (2003) 
Naamine G (17) Cladosporium herbarum  Hassan et al. (2004) 
 
The studies on screenings of marine organisms for 
antimicrobial activity lead to the isolation and 
characterisation of a wide range of bioactive 
metabolites.  
 
More than 800 antibiotic metabolites have been 
isolated from marine sponges (Torres et al., 2002), 
and new metabolites are being discovered every 
year. A total of 62 metabolites from marine 
sponges with potent antimicrobial activity were 
reported in the literature within the period of 2001 
to 2008 (Mayer and Hamann, 2005; Mayer et al., 
2007; 2009; 2011; Majali et al., 2015). As the 
secondary metabolite composition of sponges is 
dominated by alkaloid and terpenes metabolites, it 
is not surprising that antimicrobial sponge natural 
products are also dominated by polyketide and 
sterol-derived metabolites.  
 
 
ALKALOIDS 
 
Heterocyclic nitrogen compounds are called 
alkaloids. Alkaloids are well-known for their 
antimicrobial activity. The occurrence of active 
antimicrobial alkaloids in sponges is widespread. 
As shown in Table 1, many potent antimicrobial 
alkaloids were isolated from marine sponges. 
 
Torres et al. (2002) reported that the metabolites of 
arenosclerins A, B, C (1-3) and haliclonacyclamine 
E (4) were isolated from Arenosclera brasiliensis. 
These isolated alkaloids showed potent antibiotic 
activity against antibiotic-resistant S. aureus (MIC 
= 5 - 400 µg/mL).  
 
N
N
H
H
OH
  
Arenosclerin A (1) 
 
 
A dimeric bromopyrrole alkaloid, nagelamide G (5) 
was isolated from Agelas sp. (Endo et al., 2004). 
Nagelamide G exhibited antibacterial activity 
against M. luteus, B. subtilis, and E. coli. Gram-
positive alkaloid inhibitor was reported for 
cribrostatin 6 (6), which was isolated from 
Cribochalina sp. sponge (Pettit et al., 2004). The 
maximum activity for Cribostatin 6 was reported 
against Streptococcus pneumoniae (MIC = 0.5 
μg/mL).  
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Goud et al. (2003) reported the isolation of 
purpuramine L (7) from Psammaplysilla purpurea. 
This alkaloid showed potent inhibition activity 
against S. aureus, B. subtilis, and C. violaceum.  
 
 
Yang et al. (2003a) reported bicyclic guanidine 
alkaloid (8) from Ptilocaulis spiculifer. 
Interestingly, the inhibition activity of 50 μg 
guanidine alkaloid was as potent as 10 μg 
gentamicin.  
 
Jang et al. (2007a) reported the isolation of the 
alkaloid isoaaptamine (9) from the marine sponge 
Aaaptos aaptos. Isoaaptamine showed potent 
antimicrobial activity against S. aureus. 
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The bis(indole) alkaloids deoxytopsentin (10) and 
hamacanthin A (11) showed potent antibacterial 
activity against S. aureus (MIC = 3.12 - 6.35 
μg/mL). These alkaloids were isolated from the 
marine sponge Spongosorites sp (Oh et al., 2005).  
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Potent marine antibacterial alkaloid was reported 
from the sponge Batzella sp. The isolated 
batzellaside A (12) showed promising 
antimicrobial activity against several antibiotic-
resistant bacterial strains with MICs less than 10 
μg/mL (Segraves and Crews, 2005).  
 
Three other alkaloids were reported with MIC less 
than 10 μg/mL including dendridine A (13) that 
were isolated from the sponge Dictyodendrilla sp. 
(Tsuda et al., 2005) and the alkaloids batzelladines 
L and M (14, 15) isolated from the Caribbean 
sponge Monanchora unguifera. 
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Only two alkaloids that showed antifungal 
activities were isolated from marine sponge in the 
period between 2001 and 2008.  
 
The alkaloid massadine (16), which was isolated 
from the marine sponge Stylissa aff. massa, showed 
promising inhibition activity against C. albicans.  
 
Imidazole alkaloid named naamine G (17) was 
isolated from the sponge Leucetta chagosensis. 
Naamine G exhibited strong antifungal activity 
against Cladosporium herbarum (Hassan et al., 
2004). 
Qaralleh et al., 2016, J. basic appl. Res 2(1): 1-7 
 
6 
 
N
H
Br
Br
NH
ONH
OH
O
NH
NH
NH2
+
NH
NH
H2N+
OH
NH
O N
H
Br
Br
 
Massadine (16) 
N N
H
NH
OH
OMe
OMe
MeO
      Naamine G (17) 
 
ACKNOWLEDGEMENT  
The author is thankful to the Department of 
Medical Support, Al-Balqa Applied University, Al-
Karak University College (Al-Karak, Jordan) for 
providing some technical facilities to accomplish 
this study. 
 
REFERENCES  
Adam, M and Abdull Rasad, M. S. B. (2015). Expression 
of Matrix Metalloproteinase-13 in Human Skin 
Melanoma Cancer Treated by Baccaurea angulata in 
vitro. Journal of Basic and Applied Research 1 (1): 
21-28 
Becerro, M. A., Lopez, N. I., Turon, X., & Uriz, M. J. 
(1994). Antimicrobial activity and surface bacterial 
film in marine sponges. Journal of Experimental 
Marine Biology and Ecology, 179(2), 195-205. 
Castillo, P. F. (2008). "Part 1.Synthesis of laureatin. Part 
2. Synthesis of glycosphingo-lipids". Dissertations 
Collection for University of Connecticut. Paper 
AAI3340876. Available at  
Debitus, C. (1998). The Fascinating world of sponge 
chemistry & chemical ecology.In C. Lévy (Ed.), 
Sponges of the New Caledonian Lagoon (pp. 61-64). 
Paris: Orstrom editions. 
Endo, T., Tsuda, M., Okada, T., Mitsuhashi, S., Shima, 
H., Kikuchi, K., et al. (2004). Nagelamides A-H, 
New Dimeric Bromopyrrole Alkaloids from Marine 
Sponge. Chart, (1), 1262-1267. 
Faulkner, D. J. (2002). Marine natural products. Natural 
Products Reports, 19: 1-48.  
Fusetani, N. (2010). Biotechnological potential of marine 
natural products. Journal of Biotechnology, 82(1), 
17-26. 
Goud, T. V., Srinivasulu, M., Reddy, V. L. N., Reddy, A. 
V., Rao, T. P., Kumar, D. S., Murty, U. S., et al. 
(2003). Two new bromotyrosine-derived metabolites 
from the sponge Psammaplysilla purpurea. Chemical 
Pharmaceutical Bulletin, 51(8), 990-993. 
Haefner, B., (2003). Drugs from the deep: marine natural 
products as drug candidates. Drug Discovery Today, 
8(12), 536-44. 
Hassan, W., Edrada, R., Ebel, R., Wray, V., Berg, A., 
Van Soest, R., Wiryowidagdo, S., Proksch, P. (2004). 
New imidazole alkaloids from the Indonesian sponge 
Leucetta chagosensis. Journal of Natural Products, 
67, 817–822. 
Jang, J.-H., Van Soest, R. W. M., Fusetani, N., & 
Matsunaga, S. (2007a). Pseudoceratins A and B, 
antifungal bicyclic bromotyrosine-derived 
metabolites from the marine sponge Pseudoceratina 
purpurea. The Journal of Organic Chemistry, 72(4), 
1211-1217. 
Kobayashi, M. (2000). In Search for Biologically active 
substances from marine sponges, (Fusetani, N., Ed.), 
Drugs from the sea. Karger, Basel, Switzerland, pp. 
46-58. 
Laport, M. S., Santos, O. C. S. & Muricy, G. (2009). 
Marine sponges: potential sources of new 
antimicrobial drugs. Current Pharmaceutical 
Biotechnology, 10 (1), 86-105. 
 
 
 
Qaralleh et al., 2016, J. basic appl. Res 2(1): 1-7 
 
7 
 
 
Majali, I., Althunibat, O and Qaralleh, H. (2015). 
Antimicrobial and Immunomodulatory activities of 
Moringa peregrine-MINIREVIEW. Journal of Basic 
and Applied Research 1 (2): 55-61.  
Majali, I., Qaralleh, H., Idid, S. Z., Saad, S.,  Susanti, D., 
Althunibat, O. (2015). Potential Antimicrobial 
Activity of Marine Sponge Neopetrosia exigua. 
Journal of basic and applied research 1 (1): 1-13 
Mayer, A. M. S. & Hamann, M. T. (2005). Marine 
pharmacology in 2001-2002: marine compounds with 
anthelmintic, antibacterial, anticoagulant, 
antidiabetic, antifungal, anti-inflammatory, 
antimalarial, antiplatelet, antiprotozoal, 
antituberculosis, and antiviral activities; affecting the 
cardiovascular, immune and nervous systems and 
other miscellaneous mechanisms of action. 
Comparative biochemistry and physiology 
Toxicology pharmacology CBP, 140(3-4), 265-286. 
Mayer, A. M. S. & Lehmann, V. K. B. (2000). Marine 
pharmacology. The Pharmacologist, 42, 62–69 
Mayer, A. M. S., Rodríguez, A. D., Berlinck, R. G. S. & 
Fusetani, N. (2011). Marine pharmacology in 2007-8: 
Marine compounds with antibacterial, anticoagulant, 
antifungal, anti-inflammatory, antimalarial, 
antiprotozoal, antituberculosis, and antiviral 
activities; affecting the immune and nervous system, 
and other miscellaneous mechanisms of action. 
Comparative biochemistry and physiology 
Toxicology pharmacology CBP, 153, 191-222. 
Mayer, A. M. S., Rodríguez, A. D., Berlinck, R. G. S. & 
Fusetani, N. (2011). Marine pharmacology in 2007-8: 
Marine compounds with antibacterial, anticoagulant, 
antifungal, anti-inflammatory, antimalarial, 
antiprotozoal, antituberculosis, and antiviral 
activities; affecting the immune and nervous system, 
and other miscellaneous mechanisms of action. 
Comparative biochemistry and physiology 
Toxicology pharmacology CBP, 153, 191-222. 
Mayer, A. M. S., Rodríguez, A. D., Berlinck, R. G. S., & 
Hamann, M. T. (2007). Marine pharmacology in 
2003-4: marine compounds with anthelmintic 
antibacterial, anticoagulant, antifungal, anti-
inflammatory, antimalarial, antiplatelet, 
antiprotozoal, antituberculosis, and antiviral 
activities; affecting the cardiovascular, immune and 
nervous system, and other miscellaneous 
mechanisms of action. Comparative biochemistry 
and physiology Toxicology pharmacology CBP, 
145(4), 553-81. 
Mayer, A. M. S., Rodríguez, A. D., Berlinck, R. G. S., & 
Hamann, M. T. (2009). Marine pharmacology in 
2005-6: Marine compounds with anthelmintic, 
antibacterial, anticoagulant, antifungal, anti-
inflammatory, antimalarial, antiprotozoal, 
antituberculosis, and antiviral activities; affecting the 
cardiovascular, immune and nervous syste. 
Biochimica et Biophysica Acta, 1790(5), 283-308.  
Muller, W. E. G., Blumbach, B. & Muller, I. M. (1999). 
Evolution of the innate and adaptive immune 
systems: relationships between potential immune 
molecules in the lowest metazoan Phylum [Profira] 
and those in vertebrates. Transplantation, 68, 1215-
27. 
Newbold, R. W., Jensen, P. R., Fenical, W., & Pawlik, J. 
R. (1999). Antimicrobial activity of Caribbean 
sponge extracts. Aquatic Microbial Ecology, 19(3), 
279-284. 
Oh, K.-B., Mar, W., Kim, S., Kim, J.-Y., Oh, M.-N., 
Kim, J.-G., Shin, D., et al. (2005). Bis(indole) 
alkaloids as sortase A inhibitors from the sponge 
Spongosorites sp. Bioorganic & Medicinal Chemistry 
Letters, 68(5), 711-715. 
Pettit, R. K., Fakoury, B. R., Knight, J. C., Weber, C. A., 
Pettit, G. R., Cage, G. D., & Pon, S. (2004). 
Antibacterial activity of the marine sponge 
constituent cribrostatin 6. Journal of Medical 
Microbiology, 53(Pt 1), 61-65. 
Pomponi, S. A. (1999). The bioprocess–technological 
potential of the sea. Journal of Biotechnology, 70(1-
3), 5-13.  
Proksch, P., Edrada, R. A., & Ebel, R. (2002). Drugs 
from the seas - current status and microbiological 
implications. Applied Microbiology and 
Biotechnology, 59(2-3), 125-34. 
Qaralleh, H.,  Idid, S., Saad, S., Susanti, D., Taher, M 
and Khleifat, K. (2010). Antifungal and antibacterial 
activities of four Malaysian sponge species 
(Petrosiidae). Journal of Medical Mycology 20 (4): 
315-320 
Rinehart, K.L. (1992). Secondary metabolites from 
marine organisms. Ciba Foundation Symposium, 
171, 236_254. 
Samuelsson, G. (2004). Drugs of natural origin, a 
textbook of pharmacognosy. Stockholm, Swedish 
Academy of Pharmaceutical Sciences. 
Satheeshkumar, P., Khan, A.b. & Senthilkumar, D. 
(2010) Marine organisms as potential supply for drug 
finding – A Review study. Middle-east journal of 
scientific research, 5(6), 514-519 
Segraves, N. L & Crews, P. A. (2005). Madagascar 
sponge Batzella sp. as a source of alkylated 
iminosugars. Journal of Natural Products, 68, 118–
121. 
Shawa, I. T., Mponda, J., Msefula, C., Manda, H.,  
Gondwe, M. and Maliwichi-Nyirenda, C. (2015). 
Brine shrimp lethality and phytochemical 
determination of aqueous extracts of Senna 
singueana, Musa paradisiaca, and Ziziphus 
mucronata in Malawi. Journal of Basic And Applied 
Research 1 (3): 82-88 
Torres, Y. R., Berlink, R. G. S., Nascimento, G. G. F., 
Fortier, S. C., Pessoa, C. & de Moraes, M. O. (2002). 
Antibacterial activity against resistant bacteria and 
cytotoxicity of four alkaloid toxins isolated from the 
marine sponge Arenosclera brasiliensis. Toxicon, 40, 
885–891. 
Tsuda, M., Takahashi, Y., Fromont, J., Mikami, Y., & 
Kobayashi, J. (2005). Dendridine A, a bisindole 
alkaloid from a marine sponge Dictyodendrilla 
species, Journal of Natural Products, 68: 1277–1278. 
Yang, S. W., Chan, T. M., Pomponi, S. A., Chen, G., 
Loebenberg, D., Wright, A., Patel, M., et al. (2003). 
Structure elucidation of a new antifungal sterol 
sulfate, Sch 575867, from a deep-water marine 
sponge (Family: Astroscleridae). The Journal of 
Antibiotics, 56(2), 186-189. 
 
 
 
 
